Video Experimental Relacionado
Updated: May 20, 2025
05:28
Demonstration of Heterologous Complexes formed by Golgi-Resident Type III Membrane Proteins using Split Luciferase Complementation Assay
Published on: September 10, 2020
2.3K
Mecanismo basado en la estructura y especificidad de la galactosiltransferasa humana β3GalT5
Jennifer M Lo1,2,3, Chih-Chuan Kung1, Ting-Jen Rachel Cheng1
1Genomics Research Center, Academia Sinica, Taipei 115, Taiwan.
Journal of the American Chemical Society
|March 25, 2025
Resumen
La β1,3-galactosiltransferasa humana 5 (β3GalT5) es crucial para la progresión del cáncer. Este estudio revela su estructura y mecanismo catalítico, ofreciendo información para el desarrollo de nuevos medicamentos contra el cáncer dirigidos a la síntesis de glicano.
Área de la Ciencia:
- La bioquímica
- Biología estructural
- Glicobiología
Sus antecedentes:
- La β1,3-galactosiltransferasa humana 5 (β3GalT5) es vital en la síntesis de los glicanos implicados en el cáncer.
- β3GalT5 es un objetivo prometedor para nuevas terapias contra el cáncer.
Objetivo del estudio:
- Elucidar las estructuras de rayos X de β3GalT5 en complejo con sustratos y análogos.
- Determinar el mecanismo catalítico y la especificidad del sustrato de β3GalT5.
Principales métodos:
- Cristalografía de rayos X de β3GalT5 con UDP-galactosa y UDP-2-fluorogalactosa.
- Análisis de complejos enzimáticos con varios aceptores de glicano en diferentes etapas de reacción.
Principales resultados:
- Estructuras determinadas de los complejos β3GalT5, que revelan la transferencia de galactosa a través de un mecanismo similar a SN2.
- Se observaron productos alternativos de hidrólisis de UDP-galactosa (galactosa, similar al oxocarbenio) a través de vías similares a SN2 y SN1 en ausencia de aceptores.
Conclusiones:
- El estudio avanza en la comprensión de la glicosilación enzimática por β3GalT5.
- Los conocimientos estructurales y mecanicistas proporcionan una base para el diseño de fármacos dirigidos a la β3GalT5 en el cáncer.
Videos de Conceptos Relacionados
01:24Oligosaccharide Assembly
2.7K
Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Multiple sugar molecules that may or may...
2.7K
01:27Glucose Transporters
22.3K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.3K
01:25Protein Glycosylation
6.6K
Glycosylation, the most common post-translational modification for proteins, serves diverse functions. Adding sugars to proteins makes the proteins more resistant to proteolytic digestion. Glycosylated proteins can act as markers and receptors to promote cell-cell adhesion. Additionally, they have many essential quality control functions in the cell, such as correct protein folding and facilitating transport of misfolded proteins to the cytosol, which can be degraded.
Glycosylation occurs in...
Glycosylation occurs in...
6.6K
00:49Ligand Binding and Linkage
4.7K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.7K
01:05Proteoglycans
3.8K
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
3.8K
01:29Protein Folding Quality Check in the RER
3.6K
ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...
3.6K